Onyekwere Charles Asabamaka, Hameed Ladi
Senior Lecturer/Consultant Gastroenterologist, Lagos State University College of Medicine/Lagos State University Teaching Hospital Ikeja, Lagos, Nigeria
Senior Medical Manager, Medical Affairs Department, Roche Pharmaceuticals, Lagos, Nigeria.
Trop Doct. 2015 Oct;45(4):231-5. doi: 10.1177/0049475514560211. Epub 2014 Dec 15.
Hepatitis B and C remain a major cause of chronic liver disease worldwide with its attendant consequences. The burden of these viral infections in sub-Saharan Africa including Nigeria rely on estimates based on small population studies in some select populations. We present the report of a population survey in Nigeria during the period 2010-2012. A total of 5,558 adults participated in the screening exercise. The minimum age recorded was 18 years, while the maximum age was 75 years. The mean ± S.D. was 36.07 ± 8.76 years. The prevalence of hepatitis B (HBsAg) among the adults screened was determined to be 6.7% while that of hepatitis C (HCV) was 0.9%. The peak prevalence for HBsAg carriage was in the third to fourth decade in keeping with childhood acquisition while of HCV antibody was in the sixth to seventh decade. Male gender was significantly associated with HBsAg carriage while we noted a higher prevalence in those within the lower socioeconomic status. Overall our findings suggest that hepatitis B is endemic in Nigeria, much less than previously reported, while the prevalence for HCV is low although reports of pockets of high prevalence exist in select populations (hospital patients including those living with HIV).
乙型肝炎和丙型肝炎仍然是全球慢性肝病的主要病因及其相关后果。包括尼日利亚在内的撒哈拉以南非洲地区这些病毒感染的负担,依赖于基于某些特定人群中小规模人口研究的估计。我们呈现了2010年至2012年期间尼日利亚一项人口调查的报告。共有5558名成年人参与了筛查活动。记录的最小年龄为18岁,最大年龄为75岁。平均年龄±标准差为36.07±8.76岁。筛查的成年人中乙型肝炎(HBsAg)的患病率确定为6.7%,而丙型肝炎(HCV)的患病率为0.9%。HBsAg携带的患病率高峰在第三至第四个十年,这与儿童期感染一致,而HCV抗体的高峰在第六至第七个十年。男性性别与HBsAg携带显著相关,同时我们注意到社会经济地位较低者的患病率较高。总体而言,我们的研究结果表明,乙型肝炎在尼日利亚是地方病,比之前报道的要少得多,而丙型肝炎的患病率较低,尽管在特定人群(包括艾滋病毒感染者在内的医院患者)中有高患病率聚集的报道。